966
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C

, &
Pages 41-47 | Received 10 Dec 2014, Accepted 05 Aug 2015, Published online: 27 Nov 2015

References

  • Alayash AI, D’Agnillo F, Buehler PW. 2007. First generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin Biol Ther. 7:665–675.
  • Bian Y, Chang TM. 2015. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artif Cells Nanomed Biotechnol. 43:1–9.
  • Bian Y, Rong Z, Chang TM. 2011. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Immobil Biotechnol. 39:127–136.
  • Bian Y, Wei G, Chang TM. 2013. Lowering of elevated tissue pCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties. Artif Cells Nanomed Biotechnol. 41:60–68.
  • Chang TM. 1964. Semipermeable microcapsules. Science. 146:524–525.
  • Chang TM. 1971. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 44:1531–1533.
  • Chang TM. 2007. Monograph on Artificial cells: Biotechnology, Nano-technology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy. Singapore/London: World Science Publisher/Imperial College Press.
  • Chang TM. 2009. Nanobiotechnology for hemoglobin-based blood substitutes. Crit Care Clin. 25:373–382.
  • Chang TM. 2012. From artificial red blood cells, oxygen carriers, oxygen therapeutics to artificial cells and nanomedicine and beyond. Artif Cells Blood Substit Immobil Biotechnol. 40:197–199.
  • Chang TM. 2014. From hemoglobin based oxygen carrier to oxygen therapeutics, blood substitutes, nanomedicine and artificial cells. In: Kim HW, Greenburg AG, Eds. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. New York, Dordrecht, London: Springer Heidelberg, pp. 3–26.
  • Chang TM. 2015. Red blood cell replacement or nanobiotherapeutics with enhanced red blood cell functions? Artif Cells Nanomed Biotechnol. 43:145–147.
  • D’Agnillo F, Chang TM. 1998. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol. 16:667–671.
  • Geers C, Gros G. 2000. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev. 80:681–715.
  • Guo C, Gynn M, Chang TM. 2015. Extraction of superoxide dismutase, catalase and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase. Artif Cells Nanomed Biotechnol. 43:157–162.
  • Guyton AC. 1991. Monograph on Text Book of Medical Physiology. W.B. Saunders Company. Amsterdam: Academic Press.
  • Hoffman A, Goldstein S, Samuni A, Borman JB., Schwalb H. 2003. Effect of nitric oxide and nitroxide SOD-mimic on the recovery of isolated rat heart following ischemia and reperfusion. Biochem Pharmacol. 66:1279–1286.
  • Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. 2008. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma. 64:1484–1497.
  • Keipert PE, Chang TM. 1988. Pyridoxylated-polyhemoglobin solution: a low viscosity oxygen-delivering blood replacement fluid with normal oncotic pressure and long-term storage feasibility. Biomater Artif Cells Artif Organs. 16:185–196.
  • Kim HW, Greenburg AG. (Eds.) 2014. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. New York, Dordrecht, London: Springer Heidelberg.
  • Moore E, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, et al. 2009. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 208:1–13.
  • Mun KC, Bae JH, Suh SI, Kim YH, Lee SH, Kim SP, et al. 2003. Effect of modified polyhemoglobin on the oxidative damage after ischemia-reperfusion in the liver. Transplant Proc. 33:126–127.
  • OPK Biotech LLC. 2011. Hemopure now approved in Russia [press release]. Retrieved from: http://www.investorvillage.com/smbd.asp?mb=1666&mid=10711724&pt=msg.
  • Powanda DD, Chang TM. 2002. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol. 30:23–37.
  • Ristagno G, Tang W, Sun S, Weil MH. 2006. Role of buccal pCO2 in the management of fluid resuscitation during hemorrhagic shock. Crit Care Med. 34:s442–s447.
  • Sims C, Seigne P, Menconi M, Monarca J, Barlow C, Pettit J, et al. 2001. Skeletal muscle acidosis correlates with the severity of blood volume loss during shock and resuscitation. J Trauma. 51:1137–1146.
  • Tronstad C, Pischke SE, Holhjem L, Tonnessen TI, Martinsen OG, Grimnes S. 2010. Early detection of cardiac ischemia using a conductometric pCO2 sensor: real-time drift correction and parameterization. Physiol Meas. 31:1241–1255.
  • Winslow R. (Ed.) 2006. Blood Substitutes. Amsterdam: Academic Press.
  • Zhao L, Zhou W, Wang J, Li S, Chen G, Liu J, et al. 2014. The properties research of polymerized human placenta hemoglobin before and after lyophilization. Artif Cells Nanomed Biotechnol. 42:78–82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.